These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of Jak kinases and STATs in cytokine signal transduction. Leonard WJ Int J Hematol; 2001 Apr; 73(3):271-7. PubMed ID: 11345192 [TBL] [Abstract][Full Text] [Related]
6. The immunohistochemical localization of signal-transduction pathway components Jak1, Jak2, Jak3, Tyk2 and STAT-1 during early enamel and dentine formation in rat molars. Tanase S; Bawden JW Arch Oral Biol; 1996 Oct; 41(10):925-40. PubMed ID: 9031700 [TBL] [Abstract][Full Text] [Related]
7. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells. Nosaka T; Kitamura T Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049 [TBL] [Abstract][Full Text] [Related]
8. Janus kinases in cytokine signalling. Ihle JN Philos Trans R Soc Lond B Biol Sci; 1996 Feb; 351(1336):159-66. PubMed ID: 8650262 [TBL] [Abstract][Full Text] [Related]
9. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases. Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416 [TBL] [Abstract][Full Text] [Related]
10. The Jak-Stat pathway in normal and perturbed hematopoiesis. Ward AC; Touw I; Yoshimura A Blood; 2000 Jan; 95(1):19-29. PubMed ID: 10607680 [No Abstract] [Full Text] [Related]
11. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT. Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487 [TBL] [Abstract][Full Text] [Related]
13. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. Li WQ; Dehnade F; Zafarullah M J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308 [TBL] [Abstract][Full Text] [Related]
14. Jaks and Stats in cytokine signaling. Ihle JN; Nosaka T; Thierfelder W; Quelle FW; Shimoda K Stem Cells; 1997; 15 Suppl 1():105-11; discussion 112. PubMed ID: 9368330 [TBL] [Abstract][Full Text] [Related]
15. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Watanabe S; Arai Ki Curr Opin Genet Dev; 1996 Oct; 6(5):587-96. PubMed ID: 8939729 [TBL] [Abstract][Full Text] [Related]
16. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F; Chiarenza A; Goffin V; Kelly PA Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989 [TBL] [Abstract][Full Text] [Related]
17. The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway. Dorsch M; Fan PD; Danial NN; Rothman PB; Goff SP J Exp Med; 1997 Dec; 186(12):1947-55. PubMed ID: 9396763 [TBL] [Abstract][Full Text] [Related]
18. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060 [TBL] [Abstract][Full Text] [Related]
19. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation. Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030 [TBL] [Abstract][Full Text] [Related]
20. Cytokines and STAT signaling. Schindler C; Strehlow I Adv Pharmacol; 2000; 47():113-74. PubMed ID: 10582086 [No Abstract] [Full Text] [Related] [Next] [New Search]